Health
Coronavirus: why combining the Oxford vaccine with Russia’s Sputnik V vaccine could make it more effective – The Conversation UK
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given could…
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of the vaccine at stopping people developing symptomatic COVID-19, two weeks after the second dose, was 70%. But this wasnt the whole picture.
This figure was based on averaging the results from two groups. In one group, which was given two full doses, the vaccine was 62% effective at stopping people developing symptoms. But in the second group, a dosing error meant that…
-
Business21 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General20 hours agoUsman Khawaja describes Perth Stadium pitch for first Ashes Test as ‘piece of shit’
-
General16 hours agoLiberals go back to basics after crawling to year’s end
-
Business21 hours ago3 of the best ASX ETFs to build significant wealth